Living in areas with lower COI levels was associated with more severe disease presentation and poorer disease control among patients with cSLE.

A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...

When most people think about arthritis or lupus, they picture adults. But for a small number of Malaysian children, these conditions ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

Survey results indicated that cutaneous lupus erythematosus (CLE) significantly affects quality of life (QOL) independently and additively in patients with systemic lupus erythematosus (SLE), with ...

Caragh Keane, daughter of Roy Keane, has bravely shared an update on her struggle with lupus, a non-contagious ... which were initially diagnosed as chilblains despite the warm weather.

The FDA’s decision to grant the designation to FT819 was based in part on early data from an ongoing Phase 1 clinical trial (NCT06308978) that’s testing the therapy in people with systemic lupus ...

Remegen Co. Ltd. emerged as a surprise challenger in the generalized myasthenia gravis space, unveiling positive phase III data of its China-approved lupus drug, telitacicept (RCT-18; Tai’ai), in the ...

Background: Systemic lupus erythematosus (SLE) is a persistent autoimmune disorder marked by dysregulation of the immune system, resulting in extensive tissue inflammation and subsequent damage.

Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty involvement and treatment with immunosuppressive medications. A detailed history and ...